Regen BioPharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-1.7M | $-1.7M | — | — |
| FY2017 | $-1.9M | $-1.9M | — | — |
| FY2018 | $-1.6M | $-1.6M | — | — |
| FY2019 | $-481.8K | $-481.8K | — | — |
| FY2020 | $18.6K | $18.6K | — | — |
| FY2021 | $-1.1M | $-1.1M | — | — |
| FY2022 | $-606.9K | $-606.9K | — | — |
| FY2023 | $-173.9K | $-173.9K | — | $348.4K |
| FY2024 | $-751.5K | $-751.5K | — | $13.0K |
| FY2025 | $-383.6K | $-383.6K | — | — |